These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1107 related articles for article (PubMed ID: 568919)

  • 1. [In vitro and in vivo sensitivity of animal and human melanomas to various chemotherapeutical agents].
    Wiskemann A; Schussmann M; Rothmann D; Schneider O
    Arch Dermatol Res; 1978 Aug; 262(3):285-99. PubMed ID: 568919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine: a novel antitumor agent active against B-16 melanoma in vivo.
    Wick MM
    J Invest Dermatol; 1978 Aug; 71(2):163-4. PubMed ID: 681787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of in vitro testing and therapeutical results in animal transplanted tumors after cytostatic treatment].
    Wayss K; Mattern J; Volm M
    Arzneimittelforschung; 1975 Jan; 25(1):77-81. PubMed ID: 50072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.
    Fodstad O; Aass N; Pihl A
    Int J Cancer; 1980 Apr; 25(4):453-8. PubMed ID: 7372371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
    Thallinger C; Werzowa J; Poeppl W; Kovar FM; Pratscher B; Valent P; Quehenberger P; Joukhadar C
    J Invest Dermatol; 2007 Oct; 127(10):2411-7. PubMed ID: 17508024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro.
    Volm M; Faufmann M; MAttern J; Wayss K
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975; 83(2):85-96. PubMed ID: 124519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity.
    Tveit KM; Fodstad O; Olsnes S; Pihl A
    Int J Cancer; 1980 Dec; 26(6):717-22. PubMed ID: 7216540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.
    Spiro T; Liu L; Gerson S
    Forum (Genova); 2000; 10(3):274-85. PubMed ID: 11007934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hamster apigmented melanoma as a model for screening of potential antineoplastic drugs.
    Stoychkov J; Dämianova M
    Neoplasma; 1977; 24():161-4. PubMed ID: 865646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma.
    Moon JH; Gailani S; Cooper MR; Hayes DM; Rege VB; Blom J; Falkson G; Maurice P; Brunner K; Glidewell O; Holland JF
    Cancer; 1975 Feb; 35(2):368-71. PubMed ID: 1111913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma.
    Wick MM
    J Natl Cancer Inst; 1979 Dec; 63(6):1465-7. PubMed ID: 292814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual addressing of thymidine synthesis pathways for effective targeting of proliferating melanoma.
    Miran T; Vogg ATJ; El Moussaoui L; Kaiser HJ; Drude N; von Felbert V; Mottaghy FM; Morgenroth A
    Cancer Med; 2017 Jul; 6(7):1639-1651. PubMed ID: 28608446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Testing of cytostatic agents on individual tumors].
    Seidel HJ
    Acta Histochem; 1968; ():Suppl 8:331+. PubMed ID: 4187466
    [No Abstract]   [Full Text] [Related]  

  • 14. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermochemotherapy for malignant melanoma: overcoming heterogeneity in drug sensitivity.
    Yamada K; Someya T; Shimada S; Nakagawa H; Kukita A; Tokita H; Tanaka N
    J Invest Dermatol; 1985 Jul; 85(1):43-6. PubMed ID: 3859551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testing the sensitivity of malignant tumors to cytostatics in vitro and in vivo. Methods and clinical experiences].
    Wüst GP
    Munch Med Wochenschr; 1973 May; 115(18):839-42. PubMed ID: 4800216
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy against human melanoma in the hamster cheek pouch.
    Dufour FD; Okada GT; Mah SG; Morton DL
    J Surg Oncol; 1980; 15(4):355-61. PubMed ID: 7453185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.
    Busch C; Geisler J; Lillehaug JR; Lønning PE
    Eur J Cancer; 2010 Jul; 46(11):2127-33. PubMed ID: 20541396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimation of tumor sensitivity in vitro. II. Studies with the solid Ehrlich carcinoma of the mouse and the GW 77, a heterotransplanted human carcinoma].
    Seidel HJ
    Z Krebsforsch; 1970; 74(2):131-40. PubMed ID: 4103128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.